MedicineWorld.Org
Your gateway to the world of medicine
Home
News
Cancer News
About Us
Cancer
Health Professionals
Patients and public
Contact Us
Disclaimer

Medicineworld.org: Medicare modernization act and chemotherapy

Back to cancer blog Blogs list Cancer blog  


Subscribe To Cancer Blog RSS Feed  RSS content feed What is RSS feed?

Medicare modernization act and chemotherapy




Cancer patients receiving chemotherapy have not noticed a restriction in their access to therapy following the enactment of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), despite the act's significant reduction in government reimbursement to oncologists, as per a new study led by scientists in the Duke Clinical Research Institute (DCRI).



Medicare modernization act and chemotherapy

Critics of the MMA often said that it would reduce patients access to chemotherapy services, because doctors would receive 30 to 40 percent less reimbursement from the government for administering therapy, said Kevin Schulman, M.D., director of the DCRIs Center for Clinical and Genetic Economics, and senior investigator on the study. Our study showed that patients actually do not perceive barriers to their access to chemotherapy and perceptions about access are really the same among patients who received therapy before the legislation went into effect, and those who received it afterwards.

The team's findings would be reported in the November 15, 2007 print edition of the journal Cancer, but also will appear earlier in the journals October 8, 2007 online edition. The study was funded by a grant from the National Patient Advocate Foundations Global Access Project, which brings together 42 national healthcare stakeholder groups -- such as pharmaceutical companies and advocacy groups -- to fund health research projects. The Project has focused on examining the MMAs consequences for patients, providers and healthcare systems.

The Duke scientists examined the results of 1421 surveys completed via the internet by 684 patients who had received chemotherapy previous to the enactment of the MMA and 737 patients who were treated after it went into effect. Respondents answered questions correlation to issues including the amount of time they waited to start chemotherapy after their initial cancer diagnosis, and how far they had to travel to get their therapys.

When the act was passed in 2003, a number of doctors and patient advocates were concerned about the consolidation of services it might necessitate, such as the moving of chemotherapy services to hospital rather than outpatient settings and the elimination of staff positions, said Joelle Friedman, a DCRI researcher and lead author on the paper. They were afraid these changes would affect patients access to care, but our study showed that these concerns turned out to be largely unwarranted.

About half of the patients surveyed in each group were under the age of 65 and half were over 65. The majority of patients in each group reported being either satisfied or very satisfied with the care they received from their oncologists, Friedman said.

The scientists also found no difference in the amount of time from diagnosis to initiation of chemotherapy between the two groups; the median lapse in time was 22 days in both groups, Friedman said.

Patients reported an average travel time of 30 minutes to the location of their chemotherapy appointments, both before and after the implementation of the act, she said.

The speculation that therapy location would change -- that patients would either be forced to travel farther for treatment or switch therapy locations in the middle of treatment -- also proved to be unfounded, Friedman said.

The MMA represented the largest overhaul of the Medicare system since it was created in 1965. Changes included a new prescription drug benefit, and a $25 billion allocation of funds to rural hospitals. One key provision, however, was a significant reduction in Medicare reimbursement to healthcare providers. Oncologists were strongly affected, due to a perception that they had been over-compensated in the past.


Posted by: Janet    Source




Did you know?
Cancer patients receiving chemotherapy have not noticed a restriction in their access to therapy following the enactment of the Medicare Prescription Drug, Improvement and Modernization Act of 2003 (MMA), despite the act's significant reduction in government reimbursement to oncologists, as per a new study led by scientists in the Duke Clinical Research Institute (DCRI).

Medicineworld.org: Medicare modernization act and chemotherapy

Main Page| Cancer blog| Cancer blogs list| Lung cancer blog| Colon cancer blog| Prostate cancer blog| Breast cancer blog| Diabetes watch blog| Heart watch blog| Allergy blog| Bladder cancer blog| Cervical cancer blog| Colon cancer news blog| Diabetes news blog| Esophageal cancer blog| Gastric cancer blog| Health news blog| Heart news blog| Infectious disease blog| Kidney watch blog| Lung disease blog| Lung cancer news blog| Mesothelioma blog| Neurology blog| Breast cancer news blog| OBGYN blog| Ophthalmology blog| Ovarian cancer blog| Cancer news blog| Pancreas cancer blog| Pediatrics blog| Prostate cancer news blog| Psychology blog| Research blog| Rheumatology blog| Society news blog| Uterine cancer blog| Weight watch blog|

Copyright statement
The contents of this web page are protected. Legal action may follow for reproduction of materials without permission.